EcoDrugPlus

Carbonic Anhydrase Xii

Ensembl ID : ENSDARG00000045644
Gene Symbol: CA12
2 Enzyme and pathways 5 Cross references
215 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSDARG00000061697
Gene Symbol: CA14
2 Enzyme and pathways 5 Cross references
209 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSDARG00000045150
Gene Symbol: CSNK1E
24 Enzyme and pathways 5 Cross references
202 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSDARG00000004325
Gene Symbol: CASP9
17 Enzyme and pathways 5 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase A

Ensembl ID : ENSDARG00000015337
Gene Symbol: COMTA
10 Enzyme and pathways 5 Cross references
168 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSDARG00000025679
Gene Symbol: COMTB
5 Cross references
211 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSDARG00000101334
Gene Symbol: CTSC
14 Enzyme and pathways 5 Cross references
239 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSDARG00000040251
Gene Symbol: CTSK
15 Enzyme and pathways 5 Cross references
240 Possible Orthologues:

Cathepsin S, Ortholog 2, Tandem Duplicate 2

Ensembl ID : ENSDARG00000013771
Gene Symbol: CTSS2.2
11 Enzyme and pathways 5 Cross references
236 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSDARG00000074656
Gene Symbol: CTSS2.1
11 Enzyme and pathways 5 Cross references
236 Possible Orthologues:

Cell Division Cycle 7 Homolog (S. Cerevisiae)

Ensembl ID : ENSDARG00000023584
Gene Symbol: CDC7
10 Enzyme and pathways 5 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSDARG00000104765
Gene Symbol: CHEK1
26 Enzyme and pathways 5 Cross references
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).